Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
23:56
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

International Liver Cancer Association 14th Annual Conference

 

September 11-13, 2020 Virtual Conference
FAQs
   
Discussion forum - International Liver Cancer Association 20th Annual Conference
    Topic - Therapy & Miscellaneous

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Nuclear Protein 1 (Nupr1) Expression Contributes To Sorafenib Resistance In Hepatocellular Carcinoma Cells Through Protective Autophagy Activation And P73 Inhibition  Melchiorre Cervello 1      9/22/2020 1:28:00 PM  
Postprogression Survival After Lenvatinib Treatment For Advanced Hepatocellular Carcinoma  Yoshiyuki Wada 1      9/22/2020 1:28:00 PM  
Pilot Study Of Transarterial Radioembolization With Yttrium-90 In Patients With Hepatocellular Carcinoma  Pablo Florez Díez 1      9/22/2020 1:28:00 PM  
Selective Internal Radiation Therapy In Patients With Hepatocellular Carcinoma: A Retrospective Danish Study Of Efficacy  Gerda Elisabeth Villadsen 1      9/22/2020 1:28:00 PM  
Immunotherapy And Immune-Related Hepatitis In Hepatocellular Carcinoma: Outcomes And Tissue Biomarker Analysis  Neehar Parikh 1      9/22/2020 1:28:00 PM  
Hepatic Arterial Infusion Chemotherapy For Post-Transplant Recurrent Hepatocellular Carcinoma After Failure Of Tyrosine Kinase Inhibitors  Jeff Louis 1      9/22/2020 1:28:00 PM  
Treatment Sequencing Options In Advanced Hepatocellular Carcinoma: Preliminary Data From A Single-Centre Retrospective Cohort  Irene Pecora 1      9/22/2020 1:28:00 PM  
Tenofovir Vs Entecavir On Post-Operative Recurrence-Free And Overall Survival Of Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma  Jonggi Choi 1      9/22/2020 1:28:00 PM  
Exposure-response analysis for nivolumab ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)  Bruno Sangro 1      9/22/2020 1:28:00 PM  
Surgical Outcomes Of Hepatocellular Carcinoma Within Milan Criteria In Our Department: Especially Assess By The Timing Of Sustained Virological Response  Yuko Takami 1      9/22/2020 1:28:00 PM  
Effects Of Molecular Target Agent Therapy In Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study  Kazufumi Kobayashi 1      9/22/2020 1:28:00 PM  
Total Tumor Volume As A Prognostic Value For Survival Following Liver Resection In Patients With Hepatocellular Carcinoma. Retrospective Cohort Study  Mohamed Abdel-Samiee 1      9/22/2020 1:28:00 PM  
Transarterial Chemoembolization Versus Transarterial Radioembolization For Patients With Hepatocellular Carcinoma: A Meta-Analysis  Neehar Parikh 1      9/22/2020 1:28:00 PM  
Third-Line Chemotherapy In Advanced Biliary Cancers (Abc): Pattern Of Care, Treatment Outcome And Prognostic Factors From A Multicenter Study.  Massimiliano Salati 1      9/22/2020 1:28:00 PM  
Post-Registration Experience Of Nivolumab Therapy In Patients With Advanced Hepatocellular Carcinoma (Hcc): An International Study.  Petros Fessas 1      9/22/2020 1:28:00 PM  
The Efficacy And Safety Of Concurrent Chemoradiotherapy In Patients With Unresectable Hepatocellular Carcinoma  Hyun Woong Lee 1      9/22/2020 1:28:00 PM  
Tumor Burden Score: A Useful Tool To Predict Immune-Related Hepatotoxicity During Immunotherapy For Hepatocellular Carcinoma  Antonio DAlessio 1      9/22/2020 1:28:00 PM  
Real-Life Experience Of Regorafenib In Patients With Advanced Hepatocellular Carcinoma In China  Jingyu Hou 1      9/22/2020 1:28:00 PM  
Sequential Treatment With Sorafenib Followed By Regorafenib In Patients With Unresectable Hepatocellular Carcinoma (HCC): Interim Analysis Of The Observational REFINE Study  Philippe Merle 1      9/22/2020 1:28:00 PM  
Effect Of Pembrolizumab (Pembro) On Hepatitis B Virus (Hbv) Load And Aminotransferase (Alt) Levels In Patients (Pts) With Advanced Hepatocellular Carcinoma (Ahcc) In Keynote-224 And Keynote-240  Neehar Parikh 1      9/22/2020 1:28:00 PM  
Hepatic Immune-Related Adverse Events During Immunotherapy: A Comparison Between Hcc And Liver Metastases From Other Solid Tumors  Antonio DAlessio 1      9/22/2020 1:28:00 PM  
Efficacy And Safety Of Lenvatinib As A Salvage Therapy Of Transarterial Treatment For Unresectable Hepatocellular Carcinoma  Jaejun Lee 1      9/22/2020 1:28:00 PM  
Survival And Morbidity Following Stereotactic Radiotherapy Of Hepatocellular Carcinoma: A 10 Year Single Institution Experience.  Hanna Mortensen 1      9/22/2020 1:28:00 PM  
       




Most viewed poster for this congress
Poster: 1
Visits: 241
Title: Pembrolizumab In Combination With Gemcitabine And Cisplatin For The Treatment Of Advanced Biliary Tract Cancer: Phase 3 Keynote-966 Trial In Progress
Authors: Robin Kelley , R.K. KELLEY, A. VOGEL, R.S. FINN, J. FURUSE, J. EDELINE, Z. REN, S.-C. SU, U. MALHOTRA, A.B. SIEGEL, J.W. VALLE
Centre: 

Poster most viewed in this topic
Poster: 103
Visits: 115
Title: Exposure-response analysis for nivolumab ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040)
Authors: Bruno Sangro ,
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert